GLP-1 Agonist plus IL-17 Inhibition in Obese Psoriatic Arthritis
GLP-1 Agonist plus IL-17 Inhibition in Obese Psoriatic Arthritis jjcush@gmail.com Thu, 01/08/2026 – 18:51
GLP-1 Agonist plus IL-17 Inhibition in Obese Psoriatic Arthritis jjcush@gmail.com Thu, 01/08/2026 – 18:51
December 2025 delivered a diverse set of advances across rheumatology , spanning autoimmune neuromuscular disease, systemic lupus erythematosus …
ACR Open Rheumatology is the official open access rheumatology journal of the American College of Rheumatology publishing quality articles, …
Nordic Registry Study on NSAID use of ~750K, w/ 34-40% under 60 yrs. 48-58% started NSAIDs before Dx of OA.
JMIR Res Protoc. 2026 Jan 8;15:e79889. doi: 10.2196/79889. ABSTRACT BACKGROUND: Rheumatoid arthritis (RA) causes pain, fatigue, joint deformity, disability, and
Clin Rheumatol. 2026 Jan 8. doi: 10.1007/s10067-025-07915-w. Online ahead of print. ABSTRACT BACKGROUND: A high incidence of cardiovascular disease (CVD)
JAMA Oncol. 2026 Jan 8. doi: 10.1001/jamaoncol.2025.5785. Online ahead of print. ABSTRACT IMPORTANCE: Cancer survivors have increased cardiovascular disease (CVD)
Swiss Med Wkly. 2017 Sep 4;147:Suppl. 224. doi: 10.4414/smw.2017.20426. NO ABSTRACT PMID:41504665 | DOI:10.4414/smw.2017.20426
Arch Osteoporos. 2026 Jan 8;21(1):20. doi: 10.1007/s11657-025-01635-z. ABSTRACT In the U.S’s largest integrated health system, during a 24-year period (1999-2022),
Int J Rehabil Res. 2026 Jan 8. doi: 10.1097/MRR.0000000000000689. Online ahead of print. ABSTRACT Quadriceps muscle weakness is a common
Swiss Med Wkly. 2018 Aug 27;148:Suppl. 231. doi: 10.4414/smw.2018.20433. NO ABSTRACT PMID:41504552 | DOI:10.4414/smw.2018.20433
Swiss Med Wkly. 2019 Aug 28;149:Suppl. 238. doi: 10.4414/smw.2019.20440. NO ABSTRACT PMID:41504431 | DOI:10.4414/smw.2019.20440
Eur Heart J. 2026 Jan 8:ehaf1048. doi: 10.1093/eurheartj/ehaf1048. Online ahead of print. ABSTRACT BACKGROUND AND AIMS: Congenital heart defects (CHD)
Intern Med J. 2026 Jan 8. doi: 10.1111/imj.70328. Online ahead of print. ABSTRACT BACKGROUND: The inaugural Australian National Oncology Mentorship
Haematologica. 2026 Jan 8. doi: 10.3324/haematol.2025.288839. Online ahead of print. ABSTRACT Not available. PMID:41504230 | DOI:10.3324/haematol.2025.288839
Front Biosci (Landmark Ed). 2025 Dec 24;30(12):46505. doi: 10.31083/FBL46505. ABSTRACT BACKGROUND: Ulcerative colitis (UC) is a chronic inflammatory disorder primarily
Lilly announced results from phase 3b TOGETHER PsA trial; 271 obese PsA pts Rx w/ combo of ixekizumab & tirzepatide
CASTLE Phase 1/2a CAR-T cell trial of 24 Tx refractory SLE, SSC, IIM pts w/ MB-CART19.1 (autologous CD19 CAR-T). Good
An advisory board comprised of 14 physicians and health care experts will be part of Healio AI’s ongoing development, providing
Does GC tapering impact serious infections in patients treated with a JAKi? This is your chance to see the latest
Do some disease-modifying anti-rheumatic drugs (DMARDs) do better than others at relieving pain despite equivalent effects on inflammation? AbbVie’s …
(MedPage Today) — Among rheumatoid arthritis (RA) patients responding to upadacitinib (Rinvoq) or adalimumab, those receiving the former had significantly
… Rheumatology Fellowship Director, Department of Medicine, Division of Rheumatology, Columbia University Irving Medical Center/NewYork-Presbyterian …
… Rheumatology.“Understanding the epidemiology of hemophagocytic lymphohistiocytosis is key to improving outcomes through increased recognition and …
Dr Teja Kapoor urges early-career clinicians not to underestimate Sjögren’s disease, which requires thorough testing and multidisciplinary collaboration. Medscape
Dr Teja Kapoor explores how cultural sensitivity and awareness can overcome barriers to timely Sjögren disease management in diverse communities.
Dr Teja Kapoor recalls a formative case to illustrate how early recognition and multidisciplinary care are transforming the management of